[Form 4] VolitionRX Limited Insider Trading Activity

Rhea-AI Filing Summary

On 6 Aug 2025 Concorde International Group Ltd. (NASDAQ: CIGL) furnished a Form 6-K reporting a 17 Jun 2025 press release. The company disclosed that it signed SG$11.621 million (≈US$9.04 million) in new, multi-year recurring-revenue contracts during Jan-May 2025. Wins span both new customers and expanded mandates at existing sites, indicating organic growth and deeper wallet share. No further details—such as contract tenure, expected annual revenue recognition, or margin impact—were provided in the filing excerpt, and Exhibit 99.1 is not included here. The information is furnished, not filed, so it is expressly not subject to Section 18 liability.

Insights

Financial Analyst

TL;DR: US$9 M in new contracts is encouraging, but materiality unclear without baseline revenue; impact judged neutral.

The announcement shows CIGL is adding recurring revenue—strategically positive for visibility and cash-flow quality. However, the filing omits contract duration, margin profile and contribution to backlog. Without knowing prior-year revenue, investors cannot gauge percentage growth. Management’s choice to furnish, rather than file, limits legal weight and detail. I therefore view the news as incrementally positive but not yet a thesis-altering event.

Industry Specialist

TL;DR: Multi-year wins signal demand resilience; recurring model enhances valuation multiples—moderately positive.

Facilities & engineering players prize long-term, recurring contracts because they smooth revenue volatility. Securing SG$11.6 M across new and existing sites suggests CIGL’s service quality is gaining traction. While size context is missing, such wins often improve customer lifetime value and retention metrics. Assuming execution, the contracts could underpin margin expansion through operating leverage, justifying a positive outlook.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reynolds Cameron John

(Last) (First) (Middle)

1489 WEST WARM SPRINGS ROAD

SUITE 110

(Street)

HENDERSON NV 89014

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2025		P		78,125(1)	A	$0.64	2,609,847	D
Common Stock								1,007,718	I	By Concord International, Inc.(2)
Common Stock								34,076	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.

2. The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.

Remarks:

	/s/ Cameron John Reynolds	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Concorde International (CIGL) announce in its August 2025 Form 6-K?

The company reported SG$11.6 million (≈US$9.0 million) in new multi-year recurring revenue contracts signed between January and May 2025.

Are the new contracts from existing or new customers?

According to the filing, the contracts cover both new clients and expanded agreements with existing customers.

Does the 6-K include revenue or earnings guidance?

No. The document only discloses the total contract value and states no additional financial metrics or guidance.

Is the information in Exhibit 99.1 legally filed or just furnished?

It is furnished, not filed, meaning it is not subject to Section 18 liabilities of the Exchange Act.

How large is SG$11.6 million in U.S. dollars?

The company estimates the amount at approximately US$9.04 million.